Literature DB >> 7912737

Optic nerve disturbances: a new form of paclitaxel neurotoxicity.

G Capri, E Munzone, E Tarenzi, F Fulfaro, L Gianni, A Caraceni, C Martini, V Scaioli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7912737     DOI： 10.1093/jnci/86.14.1099

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Authors:  Scott M Monfort; Xueliang Pan; Robyn Patrick; Bhuvaneswari Ramaswamy; Robert Wesolowski; Michelle J Naughton; Charles L Loprinzi; Ajit M W Chaudhari; Maryam B Lustberg
Journal:  Breast Cancer Res Treat       Date:  2017-04-03       Impact factor: 4.872

2.  Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.

Authors:  H I Tahsildar; B F Remler; R J Creger; B W Cooper; S M Snodgrass; R W Tarr; H M Lazarus
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

3.  Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case.

Authors:  V Scaioli; A Caraceni; C Martini; E Palazzini; E Tarenzi; F Fulfaro; E Munzone
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 4.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 5.  Breast cancer medications and vision: effects of treatments for early-stage disease.

Authors:  Alvin Eisner; Shiuh-Wen Luoh
Journal:  Curr Eye Res       Date:  2011-08-05       Impact factor: 2.424

6.  Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report.

Authors:  Thomas P Moloney; Wen Xu; Kristopher Rallah-Baker; Niara Oliveira; Natasha Woodward; Jonathon J Farrah
Journal:  BMC Ophthalmol       Date:  2014-02-24       Impact factor: 2.209

7.  Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review.

Authors:  Ying Li; Yanping Li; Junyu Li; Guoliang Pi; Wenyong Tan
Journal:  Onco Targets Ther       Date:  2014-07-31       Impact factor: 4.147

8.  Bilateral intermediate uveitis following treatment with paclitaxel in a patient with invasive ductal carcinoma of the breast.

Authors:  Michael Kvopka; Justine R Smith; Bogda Koczwara; Stewart R Lake
Journal:  Int J Retina Vitreous       Date:  2022-09-06

Review 9.  Overview of Ocular Side Effects of Selinexor.

Authors:  Nagham Al-Zubidi; Dan S Gombos; David S Hong; Vivek Subbiah; Siqing Fu; Jordi Rodon Ahnert; Sarina A Piha-Paul; Apostolia M Tsimberidou; Daniel D Karp; Funda Meric Bernstam; Aung Naing
Journal:  Oncologist       Date:  2021-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.